Literature DB >> 31933973

miR-137 functions as a tumor suppressor gene in pituitary adenoma by targeting AKT2.

Jian Duan1, Guohui Lu1, Youping Li1, Shufeng Zhou1, Dongwei Zhou1, Hong Tao1.   

Abstract

Pituitary adenoma is a common intracranial tumor, but the underlying molecular carcinogenesis mechanisms remain unclear. Accumulative evidence has demonstrated that aberrant expression of microRNAs (miRNAs) is an important feature of cancer. The aim of the current study was to explore the role of miR-137 in pituitary tumor. The expression level of miR-137 in pituitary tumor tissues was measured by quantitative RT-PCR. Then the effects of miR-137 upregulation/downregulation on the proliferation and invasion as well as the potential molecular mechanisms were further investigated. Our results showed that the expression level of miR-137 was significantly reduced in pituitary tumor tissues compared to normal controls. Ectopic expression of miR-137 inhibited the proliferation and invasion of pituitary tumor cells, while miR-137 suppression promoted the proliferation and invasion capacity of cancer cells. Bioinformatic analysis of the downstream targets of miR-137 revealed that many enriched gene ontology functions and pathways were closely associated with carcinogenesis. Mechanically, AKT2 was demonstrated to be a direct downstream target of miR-137. The expression level of miR-137 was negatively correlated with AKT2 in pituitary tumor tissues. Taken together, miR-137 plays a tumor suppressive role in pituitary adenoma through regulating AKT2. IJCEP
Copyright © 2019.

Entities:  

Keywords:  AKT2; Pituitary adenoma; invasion; miR-137; proliferation

Year:  2019        PMID: 31933973

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  7 in total

1.  Prognostic Value of miR-137 in Children with Medulloblastoma and its Regulatory Effect on Tumor Progression.

Authors:  Wenyuan Ji; Xuan Zhe; Lusheng Li; Yang Cheng; Xueling Zhao; Ping Liang; Chunxi Long; Jianjun Zhou
Journal:  Neuromolecular Med       Date:  2021-08-18       Impact factor: 3.843

2.  LncRNA NCK1-AS1 Promotes Malignant Cellular Phenotypes of Laryngeal Squamous Cell Carcinoma via miR-137/NCK1 Axis.

Authors:  Lanlan Wan; Dongsheng Gu; Xin Jin
Journal:  Mol Biotechnol       Date:  2022-02-26       Impact factor: 2.860

3.  Long Non-Coding RNA NCK1-AS1 Serves an Oncogenic Role in Gastric Cancer by Regulating miR-137/NUP43 Axis.

Authors:  Wenxing Li; Jiming Duan; Wenbin Shi; Liqiang Lei; Pin Lv
Journal:  Onco Targets Ther       Date:  2020-10-06       Impact factor: 4.147

4.  Functional Screen for microRNAs Suppressing Anchorage-Independent Growth in Human Cervical Cancer Cells.

Authors:  Angelina Huseinovic; Annelieke Jaspers; Annina P van Splunter; Hanne Sørgård; Saskia M Wilting; Dorian R A Swarts; Ida H van der Meulen; Victor W van Beusechem; Renée X de Menezes; Renske D M Steenbergen
Journal:  Int J Mol Sci       Date:  2022-04-26       Impact factor: 6.208

5.  Caveolin-1 regulates the expression of miR-183 and inhibits the invasion and migration of invasive pituitary adenomas by affecting early growth response 1 (EGR1)/Krueppel-like factor 5 (KLF5) interaction.

Authors:  Huan Ma; Zheying Zhang; Yang Wang; Fei Shang; Baoshun Du; Yungang Wang; Zhenguo Cheng
Journal:  Gland Surg       Date:  2020-12

6.  Long non-coding RNA p53 upregulated regulator of p53 levels (PURPL) promotes the development of gastric cancer.

Authors:  Zhonghua Cheng; Jing Hong; Nan Tang; Fenghua Liu; Shuo Gu; Zhen Feng
Journal:  Bioengineered       Date:  2022-01       Impact factor: 3.269

7.  Circ_0025908 regulates cell vitality and proliferation via miR-137/HIPK2 axis of rheumatic arthritis.

Authors:  Xiaofeng Wang; Zhiwen Zhang; Haofeng Liang; Ruixiong Chen; Yuliang Huang
Journal:  J Orthop Surg Res       Date:  2021-07-30       Impact factor: 2.359

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.